A new thrombolytic regimen for acute myocardial infarction using combination half dose tissue-type plasminogen activator with full dose streptokinase: A pilot study
Cindy L. Grines(Northside Hospital), Anthony N. DeMaria(University of California System), David C. Booth(University of Kentucky), John C. Gurley(University of Kentucky), Marcelo C Branco(University of Kentucky), Kim A. Bennett(University of Kentucky), Steven E. Nissen(Cleveland Clinic)
Cited by 60
Related Papers
Effect of Rosiglitazone on the Risk of Myocardial Infarction and Death from Cardiovascular Causes
|New England Journal of Medicine|2007|4.7k
A Prospective, Single-Arm, Multicenter Trial of Ultrasound-Facilitated, Catheter-Directed, Low-Dose Fibrinolysis for Acute Massive and Submassive Pulmonary Embolism
|JACC: Cardiovascular Interventions|2015|929
Cardiovascular Safety of Celecoxib, Naproxen, or Ibuprofen for Arthritis
|New England Journal of Medicine|2016|846
State of the Art: Using Natriuretic Peptide Levels in Clinical Practice
|European Journal of Heart Failure|2008|837